Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Chris Lamb

Newcastle AuthorsTitleYearFull text
Dr Chris Lamb
Dr David Nylander
Enterobius vermicularis infection associated with positive faecal occult blood testing and eosinophilia2021
Dr Chris Lamb
Anti-SARS-CoV2 antibody responses are attenuated in patients with inflammatory bowel disease treated with infliximab2021
Dr Sesha Subramanian
Dr Marcus Brookes
Dr Chris Lamb
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study2021
Dr Chris Lamb
Inflammatory Bowel Disease Clinical Service Recovery during the COVID-19 Pandemic2021
Dr Chris Lamb
Jamie Macdonald
Infliximab and immunomodulators reduce the immunogenicity of a single dose of ChAdOx1 nCoV-19 and BNT162b2 SARS-CoV-2 vaccines2021
Dr Chris Lamb
Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD - Challenges and future directions2021
Dr Chris Lamb
Dr Marcus Brookes
Dr Sesha Subramanian
Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications - reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study2021
Dr Ashley Hart
Jamie Macdonald
Dr Sesha Subramanian
Dr Ramesh Arasaradnam
Dr Chris Lamb
et al.
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement2021
Dr Chris Lamb
Dr Marcus Brookes
The impact of SARS-CoV-2 variants on IBD management2021
Dr Chris Lamb
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel2020
1234567